Vioxx can kill you months
after you stop taking it

Back in 2004, the drug company Merck took its painkiller rofecoxib off the market. You know it as Vioxx. They took Vioxx off the market after studies showed that it substantially increased the risk of heart disease and death in those taking it. Now a new study shows that even after people stopped taking Vioxx, they were still at risk. In fact, they had twice the risk of having blood clots or dying for the next six months.

In the new study, researchers looked at 617 patients. Some of them took Vioxx for at least a year, and some took a placebo pill. Six months after stopping their pills, 22 of the patients on Vioxx developed blood clots, and 23 died. Among those taking the placebo, six developed clots, and a total of nine had died.

This is easy to understand because Vioxx is in the class of drugs we call Cox-2 inhibitors. These drugs alter the delicate balance that the body must maintain in order to make sure that our blood clots enough but not too much.

Continued Below...

The only Cox-2 drug still left on the market is celecoxib, better known as Celebrex.

If you are on Celebrex, my best advice to you is to see a doctor who knows how to help you naturally. Most patients on Celebrex take it for aches and pains. But you don’t need Celebrex. You can treat most aches and pains naturally. Just last month, I was able to get three patients off Celebrex when we cured their pain using Prolozone®.

Other natural alternatives for pain include fish oil, boswellia, turmeric, ginger, and glucosamine.  You can find the last four in Advanced Joint Support. Take three of these capsules and one 1,000 mg concentrated fish oil twice a day for six weeks.

In most cases, these supplements will work as well as Celebrex without the risks. The same warning goes for the other drugs similar to Cox-2 drugs, including naproxen (Aleve) and ibuprofen (Advil). If you are taking these drugs regularly, stop. See if you can take care of your symptoms naturally. They will have much fewer risks.

Finding your Real Cures,

Frank Shallenberger, MD

REF: Ross JS, Madigan D, Konstam MA, Egilman DS, Krumholz HM. Persistence of cardiovascular risk after rofecoxib discontinuation. Arch Intern Med. 2010 Dec 13;170(22):2035-6.

Copyright 2011 Soundview Publishing, LLC

If someone forwarded you this email, and you'd like to receive your own Real Cures Alert, please sign up on our website: www.secondopinionnewsletter.com

We have a strict anti-spam policy. We know how important your privacy is to you. That's why we do not share your email address with anyone.

Click here to read our Privacy Policy

To contact us:
Real Cures
PO Box 8051
Norcross, GA 30091-8051
800-610-5605
770-399-5617

[email protected]

Real Cures Health Alert is a complimentary e-mail service from Real Cures Newsletter written by Dr. Frank Shallenberger.

To unsubscribe from future mailings, please follow this link to manage your email preferences.